Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,246 GBX | -0.58% | +1.06% | +15.53% |
May. 14 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
May. 14 | ASTRAZENECA : Buy rating from JP Morgan | ZD |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AZN Stock
- Revisions AstraZeneca PLC